Charles Schwab’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $96.6K | Sell |
|
|||||
|
2024
Q4 | $447K | Hold |
|
|||||
|
2024
Q3 | $591K | Hold |
|
|||||
|
2024
Q2 | $628K | Buy |
|
|||||
|
2024
Q1 | $1.33M | Sell |
|
|||||
|
2023
Q4 | $715K | Buy |
|
|||||
|
2023
Q3 | $374K | Sell |
|
|||||
|
2023
Q2 | $2.7M | Buy |
|
|||||
|
2023
Q1 | $3M | Buy |
|
|||||
|
2022
Q4 | $3.93M | Buy |
|
|||||
|
2022
Q3 | $4.35M | Sell |
|
|||||
|
2022
Q2 | $3.03M | Buy |
|
|||||
|
2022
Q1 | $1.85M | Sell |
|
|||||
|
2021
Q4 | $3.04M | Buy |
|
|||||
|
2021
Q3 | $4.55M | Buy |
|
|||||
|
2021
Q2 | $5.6M | Buy |
|
|||||
|
2021
Q1 | $5.99M | Buy |
|
|||||
|
2020
Q4 | $9.53M | Buy |
|
|||||
|
2020
Q3 | $6.58M | Buy |
|
|||||
|
2020
Q2 | $2.78M | Buy |
|
|||||
|
2020
Q1 | $502K | Buy |
|
|||||
|
2019
Q4 | $488K | Hold |
|
|||||
|
2019
Q3 | $135K | Hold |
|
|||||
|
2019
Q2 | $345K | Buy |
|
|||||
|
2019
Q1 | $184K | Buy |
|
|||||
|
2018
Q4 | $100K | Sell |
|
|||||
|
2018
Q3 | $281K | Buy |
|
|||||
|
2018
Q2 | $438K | Buy |
|
|||||
|
2018
Q1 | $321K | Buy |
|